ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Giant Cell Arteritis: A Retrospective Study to Compare Efficacy and Rapidity of These Steroid-sparing Agents in GCA Patients

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Giant Cell Arteritis: A Retrospective Study to Compare Efficacy and Rapidity of These Steroid-sparing Agents in GCA Patients

By Highlights from ACR Convergence 2023 FEATURING Elena Treppo

0 views

December 15, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology. ...
read more ↘

View American College of Rheumatology educational opportunities here https://rheumatology.org/events-programs
↖ read less

Comments 0

A Treatment Option for Chronic Rhinosinusitis With Nasal Polyps

Feat. C. Franzese

An Efficacy and Safety Review for Patients With Severe Eosinophilic …

Feat. Y. Goldman

Management of Raynaud’s Phenomenon